Journal of Community Health

, Volume 44, Issue 1, pp 172–177 | Cite as

Prevalence of Concurrent Prescription Opioid and Hazardous Alcohol Use Among Older Women: Results from a Cross-Sectional Study of Community Members

  • Mirsada SerdarevicEmail author
  • Kelly K. Gurka
  • Catherine W. Striley
  • Krishna Vaddiparti
  • Linda B. Cottler
Original Paper


Concurrent use of prescription medications and alcohol is prevalent among older adults and impacts women more than men, however little is known about characteristics of older women who use both. The current analysis aims to evaluate those characteristics. Participants were recruited through HealthStreet, an outreach program. Community health workers (CHWs) assess health needs and concerns among community members. CHWs collect demographic, substance use, and other health data from participants. Female participants (≥ 50 years) interviewed November 2011–November 2017 were included and stratified into four groups: neither prescription opioid nor hazardous alcohol use (three or more drinks in a single day), hazardous alcohol use only, prescription opioid use only, and both prescription opioid and hazardous alcohol use. Chi square and ANOVA tests were used to compare these groups. Among the 2370 women (53% black; mean age 61 years), 70% reported neither prescription opioid nor hazardous alcohol use, 12% reported hazardous alcohol use only, 15% reported prescription opioid use only, and 3% reported use of both in the past 30 days. Concurrent prescription opioid and hazardous alcohol use were significantly associated with comorbid depression and anxiety (p < 0.0001); women who endorsed prescription opioid use only were significantly more likely to report a history of back pain, cancer, or diabetes compared to their counterparts (p < 0.0001). Nearly a third of women reported prescription opioid and/or hazardous alcohol use in the past 30 days. Because the risk and consequences of concomitant alcohol and opioid use increase with age, interventions tailored to women are needed.


Prescription opioids Drinking Women Community-engaged research 



Funding was provided by National Institutes of Health and National Clinical and Translational Science Award with Grant No. UL1, TR000064 and National Institute on Drug Abuse with Grant No. T32DA035167.

Compliance with Ethical Standards

Conflict of interest

The authors report no relevant financial conflicts.


  1. 1.
    Dedert, E., et al. (2014). e-Interventions for alcohol misuse. Washington (DC): Department of Veterans Affairs.Google Scholar
  2. 2.
    Alcohol Facts and Statistics | National Institute on Alcohol Abuse and Alcoholism (NIAAA). [Online]. Accessed 04 August 2016.
  3. 3.
    Wu, L.-T., & Blazer, D. G. (2014). Substance use disorders and psychiatric comorbidity in mid and later life: A review. International Journal of Epidemiology, 43(2), 304–317.CrossRefPubMedGoogle Scholar
  4. 4.
    Breslow, R. A., Castle, I.-J. P., Chen, C. M., & Graubard, B. I. (2017). Trends in alcohol consumption among older Americans: National Health Interview Surveys, 1997 to 2014. Alcoholism, Clinical and Experimental Research, 41(5), 976–986.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Use and Misuse of Alcohol Among Older Women. [Online]. Accessed 24 April 2017.
  6. 6.
    Koechl, B., Unger, A., & Fischer, G. (2012). Age-related aspects of addiction. Gerontology, 58(6), 540–544.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    West, N. A., & Dart, R. C. (May 2016). Prescription opioid exposures and adverse outcomes among older adults. Pharmacoepidemiology and Drug Safety, 25(5), 539–544.CrossRefPubMedGoogle Scholar
  8. 8.
    West, N. A., Severtson, S. G., Green, J. L., & Dart, R. C. (2015). Trends in abuse and misuse of prescription opioids among older adults. Drug and Alcohol Dependence, 149(Supplement C), 117–121.CrossRefPubMedGoogle Scholar
  9. 9.
    Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of dsm-iv drug abuse and dependence in the united states: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64(5), 566–576.CrossRefPubMedGoogle Scholar
  10. 10.
    Breslow, R. A., Dong, C., & White, A. (2015). Prevalence of alcohol-interactive prescription medication use among current drinkers: United States, 1999 to 2010. Alcoholism, Clinical and Experimental Research, 39(2), 371–379.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Gudin, J. A., Mogali, S., Jones, J. D., & Comer, S. D. (2013). Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use. Postgraduate Medicine, 125(4), 115–130.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Moore, A. A., Whiteman, E. J., & Ward, K. T. (2007) Risks of combined alcohol/medication use in older adults. The American Journal of Geriatric Pharmacotherapy, 5(1), 64–74.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Breslow, R. A., Faden, V. B., & Smothers, B. (2003). Alcohol consumption by elderly Americans. Journal of Studies on Alcohol, 64(6), 884–892.CrossRefPubMedGoogle Scholar
  14. 14.
    Merrick, E. L., et al. (2008). Unhealthy drinking patterns in older adults: Prevalence and associated characteristics. Journal of the American Geriatrics Society, 56(2), 214–223.CrossRefPubMedGoogle Scholar
  15. 15.
    NIAAA Publications. [Online]. Accessed 29 July 2016.
  16. 16.
    Hasin, D., Samet, S., Nunes, E., Meydan, J., Matseoane, K., & Waxman, R. (2006). Diagnosis of comorbid psychiatric disorders in substance users assessed with the psychiatric research interview for substance and mental disorders for DSM-IV. American Journal of Psychiatry, 163(4), 689–696.CrossRefPubMedGoogle Scholar
  17. 17.
    Helzer, J. E., & Pryzbeck, T. R. (1988). The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. Journal of Studies on Alcohol, 49(3), 219–224.CrossRefPubMedGoogle Scholar
  18. 18.
    Cicero, T. J., Lynskey, M., Todorov, A., Inciardi, J. A., & Surratt, H. L. (2008). Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse. PAIN, 139(1), 127–135.CrossRefPubMedGoogle Scholar
  19. 19.
    Green, T. C., Grimes Serrano, J. M., Licari, A., Budman, S. H., & Butler, S. F. (Jul. 2009). Women who abuse prescription opioids: Findings from the Addiction Severity Index-Multimedia Version® Connect prescription opioid database. Drug and Alcohol Dependence, 103(1–2):65–73.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Centers for Disease Control and Prevention (CDC). (2013). Vital signs: overdoses of prescription opioid pain relievers and other drugs among women—United States, 1999–2010. Morbidity and Mortality Weekly Report, 62(26), 537–542.Google Scholar
  21. 21.
    Hasin, D. S., Goodwin, R. D., Stinson, F. S., & Grant, B. F. (2005). Epidemiology of major depressive disorder: Results from the national epidemiologic survey on alcoholism and related conditions. Archives of General Psychiatry, 62(10), 1097–1106.CrossRefPubMedGoogle Scholar
  22. 22.
    Grant, B. F., Stinson, F. S., & Dawson, D. A., et al. (2004). Prevalence and co-occurrence of substance use disorders and independentmood and anxiety disorders: Results from the national epidemiologic survey on alcohol and relatedconditions. Archives of General Psychiatry, 61(8), 807–816.CrossRefPubMedGoogle Scholar
  23. 23.
    Grant, B. F., & Weissman, M. M. (2007). Gender and the prevalence of psychiatric disorders. In W. E. Narrow, M. B. First, P. J. Sirovatka & D. A. Regier (Eds.), Age and gender considerations in psychiatric diagnosis: A research agenda for DSM-V (pp. 31–45). Arlington: American Psychiatric Publishing, Inc.Google Scholar
  24. 24.
    Epidemiology of analgesic use: A gender perspective: European Journal of Anaesthesiology (EJA), LWW. Accessed 29 July 2016.
  25. 25.
    Serdarevic, M., Striley, C. W., & Cottler, L. B. (Jul. 2017). Sex differences in prescription opioid use. Current Opinion in Psychiatry, 30(4), 238–246.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Meeting, A. P. A. (2011) Mental health in public health: The next 100 years. New York: Oxford University Press.Google Scholar
  27. 27.
    SAS Institute Inc., 9.4, SAS Institute Inc., Cary, NC (2011).Google Scholar
  28. 28.
    Products - Data Briefs - Number 189 - February 2015. [Online]. Accessed 18 July 2016.
  29. 29.
    Simoni-Wastila, L., The Use of Abusable Prescription Drugs. (2000). The role of gender. Journal of Women’s Health & Gender-Based Medicine, 9(3), 289–297.CrossRefGoogle Scholar
  30. 30.
    Darnall, B. D., Stacey, B. R., & Chou, R. (2012). Medical and psychological risks and consequences of long-term opioid therapy in women. Pain Medicine, 13(9), 1181–1211.CrossRefPubMedGoogle Scholar
  31. 31.
    Nguyen, L. M. T., et al. (2013). Frequency and predictors of patient deviation from prescribed opioids and barriers to opioid pain management in patients with advanced cancer. Journal of Pain and Symptom Management, 45(3), 506–516.CrossRefPubMedGoogle Scholar
  32. 32.
    Luo, X., Pietrobon, R., & Hey, L. (2004) Patterns and trends in opioid use among individuals with back pain in the United States. Spine, 29(8), 884–890; discussion 891.CrossRefPubMedGoogle Scholar
  33. 33.
    CDC - Fact Sheets-Excessive Alcohol Use and Risks to Women’s Health - Alcohol. [Online]. Accessed 29 July 2016.
  34. 34.
    Colby, S. L., & Ortman, J. M. (2015) Projections of the size and composition of the US population: 2014 to 2060. US Census Bureau, Ed., pp. 25–1143.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Mirsada Serdarevic
    • 1
    Email author
  • Kelly K. Gurka
    • 1
  • Catherine W. Striley
    • 1
  • Krishna Vaddiparti
    • 1
  • Linda B. Cottler
    • 1
  1. 1.Department of EpidemiologyUniversity of FloridaGainesvilleUSA

Personalised recommendations